CMS issues new drug rules to save $17B

The Centers for Medicare & Medicaid Services (CMS) has issued new rules expected to cut Medicaid spending on drugs by about $17.7 billion over the next five years, according to Bloomberg. The savings will be achieved primarily from shifting more costs to pharmaceutical manufacturers and pharmacies. The new rule "puts in place simple measures that will cut costs, increase transparency and benefit consumers," CMS acting administrator Marilyn Tavenner said in a press release Friday. Statement

Suggested Articles

The Centers for Medicare & Medicaid Services released the MA plan star ratings for the 2020 plan year on Friday.

A New Orleans-based genetic testing company will pay $42.6 million to resolve False Claims Act and kickback allegations.

FierceHealthcare caught up with former ONC and Veterans Affairs' official Genevieve Morris for our latest Executive Spotlight.